530233 — Auro Laboratories Cashflow Statement
0.000.00%
- IN₹1.52bn
- IN₹1.77bn
- IN₹536.35m
- 61
- 13
- 74
- 49
Annual cashflow statement for Auro Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 56.4 | 105 | 38.7 | 34.5 | 103 |
Depreciation | |||||
Non-Cash Items | 5.08 | 2.96 | 5.86 | 12.7 | 11.2 |
Other Non-Cash Items | |||||
Changes in Working Capital | 20.2 | 9.79 | -121 | -25.1 | 62.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 91.9 | 128 | -65.9 | 32.8 | 188 |
Capital Expenditures | -6.72 | -3.75 | -46.1 | -40.7 | -356 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -15.4 | -31.3 | -7.33 | -10.1 | -30.3 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -22.1 | -35.1 | -53.4 | -50.8 | -387 |
Financing Cash Flow Items | -4.66 | -4.58 | -8.26 | -8.14 | -7.36 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -54 | -4.56 | 97.9 | -81.8 | 191 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 15.8 | 88.5 | -21.4 | -99.8 | -7.68 |